{"product_id":"networks-of-innovation-vaccine-development-at-merck-sharp-and-dohme-and-mulford-1895-1995-paperback-softback-9780521626200","title":"Networks of Innovation; Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995 (Paperback \/ softback) 9780521626200","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNetworks of Innovation\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eVaccine Development at Merck, Sharp and Dohme, and Mulford, 1895–1995\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eHow private organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market antitoxins and vaccines.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eLouis Galambos (Author), Jane Eliot Sewell (With)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521626200, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 13 August 1997\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e288 pages, 4 colour illus.\u003cbr\u003e22.7 x 15.3 x 2 cm, 0.44 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eNetworks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck \u0026amp; Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003e 1. 1894: 'The foremost medical question of the day'\u003cbr\u003e 2. The Mulford story\u003cbr\u003e 3. A Sharp \u0026amp; Dohme interlude\u003cbr\u003e 4. The virology network and a new programme at Merck, Sharp \u0026amp; Dohme\u003cbr\u003e 5. Hilleman's innovations: first phase, measles-mumps-rubella\u003cbr\u003e 6. Dangerous interlude, Marek's Disease adjuvant 65, the Swine Flu drama\u003cbr\u003e 7. Transforming bacteriology: a second phase, meningitis, pneumonia, haemophilus, influenzae\u003cbr\u003e 8. New networks, new leadership: the Hepatitis B vaccines\u003cbr\u003e 9. Vaccine innovation in the nineties: new strategies, new structures, and public confrontations\u003cbr\u003e A word about sources.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: History of medicine [\u003ca title=\"See our other books on History of medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22History%20of%20medicine%20%5BMBX%5D%22\"\u003eMBX\u003c\/a\u003e], Pharmaceutical industries [\u003ca title=\"See our other books on Pharmaceutical industries\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pharmaceutical%20industries%20%5BKNDP%5D%22\"\u003eKNDP\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Brand New","offer_id":52316747464984,"sku":"9780521626200","price":26.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9780521563086.gif?v=1781823689","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/networks-of-innovation-vaccine-development-at-merck-sharp-and-dohme-and-mulford-1895-1995-paperback-softback-9780521626200","provider":"Freshly Printed Books","version":"1.0","type":"link"}